Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (141-150 of 340) with videos related to

Pageof 34
Sort By:
The American Journal of Gastroenterology|May 7, 2014
Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progressionFernando Magro, Eduardo Rodrigues-Pinto, Rosa Coelho, et al.
United European Gastroenterology Journal|June 30, 2021
COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterologyFernando Magro, Alexandre Nuzzo, Cândida Abreu, et al.
United European Gastroenterology Journal|September 6, 2023
Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel diseasePauline Wils, Vipul Jairath, Bruce E Sands, et al.
Current Drug Targets|February 4, 2021
Inflammatory Bowel Disease in Migrant Populations: Should we Look Even Further Back?Gionata Fiorino, Maria M Estevinho, Diogo J M Lopes, et al.
European Journal of Gastroenterology & Hepatology|October 16, 2003
High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel diseaseFernando Magro, Mario Dinis-Ribeiro, Fernando M Araújo, et al.
Clinical Chemistry and Laboratory Medicine|April 25, 2023
Dipeptidyl peptidase 4 (DPP4) in fecal samples: validation of the extraction methodology and stability in short-term storage conditionsSandra F Gomes, Francisco Jorge Melo, Rita Silva, et al.
Journal of Crohn'S & Colitis|April 21, 2025
5-Aminosalicylates for non-surgical patients with active or quiescent Crohn's disease: an overview of systematic reviews (umbrella review)Abdulaziz Alajmi, Yuhong Yuan, Virginia Solitano, et al.
Journal of Crohn'S & Colitis|December 17, 2013
Crohn's disease outcome in patients under azathioprine: a tertiary referral center experienceFernando Magro, João Santos-Antunes, Filipe Vilas-Boas, et al.
Journal of Crohn'S & Colitis|August 13, 2013
High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatmentFernando Magro, Eduardo Rodrigues-Pinto, João Santos-Antunes, et al.
Inflammatory Bowel Diseases|May 13, 2025
Developing IBD Outcome Effect Size Thresholds to Inform Research, Guidelines, and Clinical DecisionsMorris Gordon, Nader Shaban, Vasiliki Sinopoulou, et al.
Pageof 34

Showing results (141-150 of 340) with videos related to

Sort By:
Pageof 34
The American Journal of Gastroenterology|May 7, 2014
Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progressionFernando Magro, Eduardo Rodrigues-Pinto, Rosa Coelho, et al.
United European Gastroenterology Journal|June 30, 2021
COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterologyFernando Magro, Alexandre Nuzzo, Cândida Abreu, et al.
United European Gastroenterology Journal|September 6, 2023
Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel diseasePauline Wils, Vipul Jairath, Bruce E Sands, et al.
Current Drug Targets|February 4, 2021
Inflammatory Bowel Disease in Migrant Populations: Should we Look Even Further Back?Gionata Fiorino, Maria M Estevinho, Diogo J M Lopes, et al.
European Journal of Gastroenterology & Hepatology|October 16, 2003
High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel diseaseFernando Magro, Mario Dinis-Ribeiro, Fernando M Araújo, et al.
Clinical Chemistry and Laboratory Medicine|April 25, 2023
Dipeptidyl peptidase 4 (DPP4) in fecal samples: validation of the extraction methodology and stability in short-term storage conditionsSandra F Gomes, Francisco Jorge Melo, Rita Silva, et al.
Journal of Crohn'S & Colitis|April 21, 2025
5-Aminosalicylates for non-surgical patients with active or quiescent Crohn's disease: an overview of systematic reviews (umbrella review)Abdulaziz Alajmi, Yuhong Yuan, Virginia Solitano, et al.
Journal of Crohn'S & Colitis|December 17, 2013
Crohn's disease outcome in patients under azathioprine: a tertiary referral center experienceFernando Magro, João Santos-Antunes, Filipe Vilas-Boas, et al.
Journal of Crohn'S & Colitis|August 13, 2013
High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatmentFernando Magro, Eduardo Rodrigues-Pinto, João Santos-Antunes, et al.
Inflammatory Bowel Diseases|May 13, 2025
Developing IBD Outcome Effect Size Thresholds to Inform Research, Guidelines, and Clinical DecisionsMorris Gordon, Nader Shaban, Vasiliki Sinopoulou, et al.
Pageof 34